Compound ID | 698
Class: Peptide deformylase inhibitor
| Spectrum of activity: | Gram-negative |
| Details of activity: | Use against CAP and Anthrax |
| Institute where first reported: | Vernalis |
| Year first mentioned: | 2002 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| Reason Dropped: | Resistance development (LS) |
| External links: | |
| Citation: | https://journals.asm.org/doi/10.1128/aac.46.4.1117-1118.2002 |